Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Minority Interest (2016 - 2025)

Cumberland Pharmaceuticals' Minority Interest history spans 16 years, with the latest figure at -$336100.0 for Q4 2025.

  • For Q4 2025, Minority Interest fell 9.29% year-over-year to -$336100.0; the TTM value through Dec 2025 reached -$336100.0, down 9.29%, while the annual FY2025 figure was -$336100.0, 9.29% down from the prior year.
  • Minority Interest for Q4 2025 was -$336100.0 at Cumberland Pharmaceuticals, down from -$319150.0 in the prior quarter.
  • Across five years, Minority Interest topped out at -$139283.0 in Q1 2021 and bottomed at -$336100.0 in Q4 2025.
  • The 5-year median for Minority Interest is -$307517.0 (2024), against an average of -$274287.4.
  • The largest annual shift saw Minority Interest plummeted 195.44% in 2021 before it grew 7.83% in 2024.
  • A 5-year view of Minority Interest shows it stood at -$212328.0 in 2021, then plummeted by 37.58% to -$292126.0 in 2022, then fell by 15.02% to -$335991.0 in 2023, then rose by 8.47% to -$307517.0 in 2024, then fell by 9.29% to -$336100.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Minority Interest are -$336100.0 (Q4 2025), -$319150.0 (Q3 2025), and -$310868.0 (Q2 2025).